The Medicines and Healthcare products Regulatory Authority has approved a new clinical trial to test whether psychedelic drugs can treat major depressive disorder. A novel…
MHRA approves London-based psychedelic drug trial
About LaingBuisson
LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education.
Contact us: [email protected]
Follow LaingBuisson
©2024 All rights reserved LaingBuisson 
